One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Veterinary Pain Management Market

[ 英語タイトル ] Veterinary Pain Management Market - Growth, Trends, and Forecast (2020 - 2025)

Product Code : MDHC0089030
Survey : Mordor Intelligence
Publish On : November, 2020
Number of Pages : 113
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Assisi Animal Health
- Boehringer Ingelheim
- Ceva Sante Animale
- Chanelle Veterinary Limited
- Dechra Pharmaceuticals PLC
- Elanco
- Norbrook
- Vetoquinol SA
- Zoetis Inc.

[Report Description]

Veterinary Pain Management market, being a competitive one, is expected to observe growth owing to the high prevalence of inflammatory and painful diseases in the animal population. According to a report published in Nature, in April 2018, the annual period prevalence of osteoarthritis diagnosis in dogs under primary veterinary care in the United Kingdom was estimated to be 2.5%. Similarly, according to the Animal Cancer Foundation, 65 million dogs and 32 million cats in the United States were diagnosed with cancer during the year 2017. Moreover, approximately 6 million new cancer diagnoses are made in pets, each year.

Additionally, as per the results of the 2017-2018 APPA (American Pet Products Association) National Pet Owners Survey, 10% of dogs and 8% each of cats and birds have undergone surgical procedures, for some reason or the other. This indicate that there is a high prevalence of the diseases associated with pain in animals which is a fuelling factor for the market studied.

In addition to the aforementioned factors, the rise in need for easily accessible and affordable treatment procedures and an increase in awareness about animal health and welfare are also expected to propel the growth of the veterinary pain management market.

Key Market Trends

Laser Therapy is Expected to Witness a Healthy Growth Over the Forecasted Period

The therapeutic laser treatment of osteoarthritis (OA) in dogs and cats is currently the most common laser therapy. The laser intensity in OA is most appropriate as 8-10 J/cm2. Tendonitis may also be benefitted from laser therapy, due to the inflammation associated with the disease.

Generally, the price of therapeutic laser equipment can range from around USD 30 to around USD 10,000, based upon the size of it, the facilities it provides, and the technologies it uses. There are some laser devices that can be used both for surgical and therapeutic purposes, by controlling the level of emission. These devices can have higher prices, even up to USD 40,000. Some of the laser therapy brands that are in the market for veterinary pain management include B-Cure Laser, TENDLITE, Lumasoothe, iReliev, Keebomed, MLS Laser Therapy (ASAveterinary), among others. The end-users primarily include pet owners, veterinary clinics, and hospitals. Owing to the aforementioned factors, the segment is expected to witness considerable growth over the forecast period.

India to Witness Rapid Growth in Asia-Pacific Region

The large livestock population in India is a major factor contributing to the market growth. According to the National Dairy Development Board, India, the total livestock population in India, as recorded in 2019, is around 536 million.

Animal husbandry has observed a significant increase over the years, in India. The factors behind the growth of the animal health market are the adoption of innovative technologies that are used to prevent and cure various diseases associated with farm and companion animals. Animal health companies now deal with therapeutics, preventive measures, and productivity enhancement.

Over the past few years, many global animal health companies, such as Ceva and Sanofi, have entered the animal health market in India, owing to large growth opportunities in the country. For example, India has approximately 120 million dairy cows, and hence, is the largest milk producer in the world, having a production capacity almost equivalent to that of the entire European Union. In addition, India is also the fifth-largest producer of chicken meat and a major exporter of beef. Therefore, owing to the rising significance of this country in the international market, it is expected to witness rapid growth.

Competitive Landscape

Veterinary healthcare has rapidly evolved over the last few years, where technology concerning biotech, genomics, artificial intelligence, cloud computing, and big data has grown massively, bringing competition among large animal health companies and collaborations with technologically advanced start-ups. Also, the industry observed significant mergers and acquisitions in recent years, such as between Boehringer Ingelheim Animal Health and Merial. Thus, the veterinary healthcare market has become a very competitive industry and this factor is beneficial for the market studied as companies are obtaining opportunities to establish their presence.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Growth in Prevalence of Painful and Inflammatory Diseases in Animals
4.2.2 Rise in Need for Easily Accessible and Affordable Treatment Procedures
4.2.3 Increase in Awareness about Animal Health and Welfare
4.3 Market Restraints
4.3.1 Side Effects Associated with Treatment
4.3.2 High Cost of Certain Products
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Product
5.1.1 Drugs NSAIDs Anesthetics Opioids Others
5.1.2 Devices Laser Therapy Electromagnetic Therapy
5.2 By Application
5.2.1 Osteoarthritis and Joint Pain
5.2.2 Postoperative Pain
5.2.3 Cancer
5.2.4 Others
5.3 By Animal Type
5.3.1 Companion
5.3.2 Livestock
5.4 By End User
5.4.1 Hospitals and Clinics
5.4.2 Retail Outlets and Others
5.5 Geography
5.5.1 North America United States Canada Mexico
5.5.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.5.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.5.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.5.5 South America Brazil Argentina Rest of South America

6.1.1 Assisi Animal Health
6.1.2 Boehringer Ingelheim
6.1.3 Ceva Sante Animale
6.1.4 Chanelle Veterinary Limited
6.1.5 Dechra Pharmaceuticals PLC
6.1.6 Elanco
6.1.7 Norbrook
6.1.8 Vetoquinol SA
6.1.9 Zoetis Inc.




Recommended reports